Holista CollTech Ltd (ASX: HCT) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Holista CollTech Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.35 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 278.80 million
Earnings per share -0.007
Dividend per share N/A
Year To Date Return -58.62%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Holista CollTech Ltd (ASX: HCT)
    Latest News

    asx share penalty represented by lots of fingers pointing at disgraced businessman Crown royal commission WA
    Healthcare Shares

    ASIC accuses ASX company of misleading COVID-19 claims

    The chief executive of the WA business allegedly said on a YouTube video that its sanitiser spray can kill the…

    Read more »


    Why the Holista CollTech share price is climbing higher today

    The Holista CollTech Limited (ASX: HCT) share price is bucking the wider market sell-off today after the company announced the…

    Read more »

    Share Market News

    ASX stock of the day: This small-cap ASX wellness share jumped 6% today after it filed a global patent

    The share price of Holista CollTech Limited (ASX: HCT)has leapt 6% today after the company announced it had filed a…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    ⏸️ Investing

    The Holista Colltech share price soars 170% today

    Holista Colltech Limited (ASX:HCT) announces major scientific breakthrough

    Read more »

    HCT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Holista CollTech Ltd

    Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. Supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. Ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. Food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. Infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from Supplements segment. Geographically, it generates a majority of its revenue from Malaysia.

    HCT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    23 Nov 2023 $0.01 $0.00 0.00% 644,291 $0.01 $0.01 $0.01
    22 Nov 2023 $0.01 $0.00 0.00% 75,000 $0.01 $0.01 $0.01
    10 Nov 2023 $0.01 $0.00 0.00% 14,285 $0.01 $0.01 $0.01
    09 Nov 2023 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    02 Nov 2023 $0.01 $0.00 0.00% 100,099 $0.01 $0.01 $0.01
    01 Nov 2023 $0.01 $0.00 0.00% 100,000 $0.01 $0.01 $0.01
    31 Oct 2023 $0.01 $0.00 0.00% 975,000 $0.01 $0.01 $0.01

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Rajendran (Rajen) Marnickavasagar (Manicka) Managing DirectorChief Executive Officer Jul 2009
    Dr Manicka began his career as an intern pharmacist at the Kuala Lumpur General Hospital from 1986 - 1987. In 1987 he spent a year as a community pharmacist. Over a period of 9 years, He worked for several pharmaceutical companies including Roche and CIBA Pharmaceuticals in various capacities starting as a medical representative, product manager and eventually as marketing manager. In 1995, he incorporated Total Health Concept. He has been a guest lecturer in alternative medicine at the University of Malaysia, the National University of Malaysia, and the International Medical University in Malaysia. He was also a health columnist for the Sunday Times. He is a member of the Malaysian Ministry of Health Standing Committee for Traditional Medicine and until March 2009 was on the board of Malaysian Herbal Corporation Sdn Bhd.

    Mr David Ross Deloub Non-Executive ChairmanNon-Executive Director Apr 2023
    Mr Deloub has 30 years experience in the finance and corporate sectors. David has held a number of executive positions including Chief Financial Officer at the ASX listed Neptune Marine Services and Executive Director at Patersons Capital Partners, a Perth based boutique advisory firm providing strategic and financial advice to ASX listed companies. David has considerable corporate finance, business development and financial market experience both in Australia the United States and Africa where he has held senior management positions at Alinta Energy Limited , Neptune Marine Services and Alcoa Inc in the US. David currently holds executive Board positions on the ASX listed Stonehorse Energy Limited and Avira Resources Limited. He has previously held a number of non-executive board positions including; Neptune Marine Services Limited, Merah Resources and Minquest Limited.
    Mrs Loren (Ann Jones) Anne King Non-Executive Director Jul 2021
    Mrs Loren King has worked in corporate finance and senior administration roles with ASX listed companies, stockbroking and corporate advisory services for the past 15 years. she has experience in dealing with all aspects of corporate governance and compliance.

    Mr Jay Richard Stephenson Company Secretary Sep 2021
    Jay Richard Stephenson Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Galen Biomedical Inc 58,514,245 20.99%
    BNP Paribas Nominees Pty Ltd 43,268,209 15.52%
    818 Corporate Pty Ltd 13,196,169 4.73%
    Ms Sarinderjit Kaur 9,675,785 3.47%
    Citicorp Nominees Pty Limited 8,086,707 2.90%
    Mr Robert Gemelli 7,915,016 2.84%
    HSBC Custody Nominees (Australia) Limited(i) 7,829,102 2.81%
    Mr Anthony Robert Ramage 7,000,000 2.51%
    Fairview Holdings Pty Ltd 6,358,570 2.28%
    Bnp Paribas Noms Pty Ltd 6,352,824 2.28%
    123 Home Loans Pty Ltd 6,100,000 2.19%
    Driscoll Future Pty Ltd 3,750,000 1.35%
    Mr Himmat Singh 3,500,000 1.26%
    Chandra Sekaran P Perumal 3,333,333 1.20%
    Perpetual Capital Investments Pty Ltd 3,000,000 1.08%
    Mr Peter Klimis 1,876,029 0.67%
    HSBC Custody Nominees (Australia) Limited(ii) 1,799,994 0.65%
    Neweconomy Com Au Nominees Pty Limited 1,709,938 0.61%
    Neo Health Sdn Bhd 1,610,613 0.58%
    Mr Kok Seng Chen 1,482,459 0.53%